NHSE1051 Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England

{
  "id": "029417-2026",
  "tag": [
    "tenderUpdate"
  ],
  "date": "2026-03-31T09:27:23+01:00",
  "ocid": "ocds-h6vhtk-066b53",
  "buyer": {
    "id": "GB-NHS-Q83",
    "name": "NHS England North West"
  },
  "tender": {
    "id": "NHSE1051",
    "title": "NHSE1051 Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England",
    "amendments": [
      {
        "id": "1",
        "description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using Direct Award Process C.\nThe contract value is £1,650,000 commencing 01 April 2026 to 31 March 2029.\nThe award decision was made on 16 March 2026 by NHS England North West Specialised Commisisoning Senior Leaders Team: \nAndrew Bibby, Regional Director of Specialised Commissioning and Health & Justice North West\nJanine Dyson, Head of Quality\nCarole Hodgkinsom, Head of Commercial Management\nSue McGorry, Director of Nursing\nFiona Simmons-Jones, Consultant in Healthcare, Public Health\nLuoise Sinnott, Head of Acute Strategy and Transformation\nCarol Stubley, Director of Finance \nThe existing provider is satisfying the existing contract and will likely satisfy the proposed new contract. The provider has been assessed and has passed against the relevant 5 key criteria and mandatory requirements award criteria which were laid out in the procurement documents.\nThere were no conflicts of interests identified."
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England.",
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-NHS-Q83",
      "name": "NHS England North West",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKD",
        "locality": "Manchester",
        "postalCode": "M1 3BN",
        "countryName": "United Kingdom"
      },
      "details": {
        "url": "https://www.england.nhs.uk/north-west/"
      },
      "identifier": {
        "id": "Q83",
        "scheme": "GB-NHS",
        "legalName": "NHS England North West"
      },
      "contactPoint": {
        "email": "necsu.neprocurement@nhs.net"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}

{
  "id": "023649-2026",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "value": 1,
        "measure": "bids",
        "relatedLot": "1"
      }
    ]
  },
  "date": "2026-03-16T15:26:39Z",
  "ocid": "ocds-h6vhtk-066b53",
  "buyer": {
    "id": "GB-NHS-Q83",
    "name": "NHS England North West"
  },
  "awards": [
    {
      "id": "023649-2026-1",
      "title": "Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England.",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-CHC-1049274",
          "name": "Manchester University Foundation Trust"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "NHSE1051",
    "lots": [
      {
        "id": "1",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) \nThis is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. \nThe Relevant Authority is intending to award a contract to the existing provider following Direct Award Process C. \nThe publication of this notice marks the start of the Standstill Period. \nRepresentations by providers must be made to decision makers by 27 March 2026. \nThis contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.\nThe contract will commence on 01 April 2026 and conclude on 31 March 2029.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard",
              "type": "quality",
              "description": "100"
            },
            {
              "name": "The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard",
              "type": "cost",
              "description": "100"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKD"
          }
        ]
      }
    ],
    "title": "NHSE1051 Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England.",
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "procurementMethod": "limited",
    "mainProcurementCategory": "services",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "The Relevant Authority  intends to issue a contract via Direct Award Process C. \nThe Relevant Authority has taken into account the key criteria and applied the basic selection criteria, and is content that the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
        "description": "The procurement falls outside the scope of application of the directive"
      }
    ]
  },
  "parties": [
    {
      "id": "GB-NHS-Q83",
      "name": "NHS England North West",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKD",
        "locality": "Manchester",
        "postalCode": "M1 3BN",
        "countryName": "United Kingdom"
      },
      "details": {
        "url": "https://www.england.nhs.uk/north-west/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "id": "Q83",
        "scheme": "GB-NHS",
        "legalName": "NHS England North West"
      },
      "contactPoint": {
        "email": "necsu.neprocurement@nhs.net"
      }
    },
    {
      "id": "GB-CHC-1049274",
      "name": "Manchester University Foundation Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKD3",
        "locality": "Manchester",
        "postalCode": "M13 9WL",
        "countryName": "United Kingdom",
        "streetAddress": "Cobbett House, Oxford Road"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "id": "1049274",
        "scheme": "GB-CHC",
        "legalName": "Manchester University Foundation Trust"
      }
    },
    {
      "id": "GB-FTS-148586",
      "name": "NHS England North West",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Manchester",
        "countryName": "United Kingdom"
      },
      "identifier": {
        "legalName": "NHS England North West"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "023649-2026-1",
      "title": "Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England.",
      "value": {
        "amount": 1650000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "023649-2026-1",
      "dateSigned": "2026-03-16T00:00:00Z"
    }
  ],
  "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the  Procurement Act 2023 do not apply to this award. \nThe publication of this notice marks the start of the Standstill Period. \nRepresentations by providers must be made to decision makers by 27 March 2026. \nThis contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.\nWritten representations should be sent to: necsu.neprocurement@nhs.net\nThe award decision was made on 16 March 2026 by the North West Specialised Commissioning Senior Leaders Team.\nThe Relevant Authority, as part of the Direct Award C process, have reviewed the key criteria.  The evidence shows that the Provider can satisfy the proposed new contract.\nThe information gathered evidences that the incumbent provider meets the key criteria and gives assurance that they can continue to provide the service within the new contract.\nThe current Provider is providing a quality service which meets the needs of the population they serve and is continually addressing and reducing inequalities in both service, access and outcomes.  It shows the current provider is treating both patients and staff with equality and are continually seeking improvements in social value including their environment.\n All involved in the process completed a conflict of interest declaration. No conflicts were identified.",
  "initiationType": "tender"
}